Skip to main content
Compass Pathways: home
  • About us

        • About us

          Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

        • About us
          • Our purpose
          • Our stories
          • Our values
          • Our approach
        • Our team
          • Executive Team
          • Board of Directors

        • Our stories

          Everyone has a story about how mental health has affected them or someone they know. Our people bring their stories, and a wide range of backgrounds and skills, to Compass.

          Read our stories
  • Our work

        • Our work

          We want to give people living with mental health challenges better options.

        • About psilocybin therapy
        • Pipeline
          • Treatment-resistant depression (TRD)
          • Post-traumatic stress disorder (PTSD)
          • Anorexia nervosa
          • Pipeline overview
          • Investigator-initiated studies
        • Therapist training
        • Preclinical research
          • Discovery Center
        • Digital technologies
          • Digital technology blog
        • Our publications and results
          • COMP360 psilocybin in healthy participants
          • COMP360 psilocybin treatment in TRD
          • COMP360 psilocybin treatment in TRD with antidepressants
          • Therapist training: Frontiers in Psychiatry
        • Partnerships and collaborations
          • Centres of Excellence
          • Partnerships
        • Our approach
          • Compassionate use policy
          • Animal welfare
        • phase II clinical trial of psilocybin therapy

        • Our blog

          Read our blog to learn more about Compass and our work.

          Read more
  • Join us

        • Join us

          We are united by our commitment to improving mental health.

        • Join us
          • Our culture
          • Benefits
          • Careers
          • 60 seconds with ...

        • Our purpose

          Watch our purpose video to find out who we are and what defines us.

          Find out more about our purpose
  • News and views

        • News and views

          Our collective understanding of mental illness is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.

        • Press releases
        • Our blog
        • Compass

        • Our blog

          Read our blog to learn more about Compass and our work.

          Read more
  • Investors

        • Investors

          We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

        • News & events
          • News
          • Events & presentations
          • Our annual review
        • Financials
          • SEC filings
          • Annual reports
          • PFIC annual information statements
        • Stock info
          • Stock quote
          • Analyst Coverage
          • Split history
        • Governance
          • Documents & charters
          • Executive Team
          • Board of directors
          • Committee composition
          • Annual general meeting
        • Resources
          • FAQs
          • Shareholder privacy notice
          • Email alerts
          • IR contacts

        • COMP360 psilocybin treatment in TRD

          We have completed the largest randomised, controlled, double-blind psilocybin treatment study ever done.

          Read more about COMP360 psilocybin treatment in TRD
  • LinkedIn
  • Youtube
  • Twitter
  • Accessibility
accessibility options
  • High Contrast
  • Greyscale
  • Negative Contrast
  • Readable
  • Reset
Contact us
george and ekaterina

Our blog

December 19, 2019

George and Ekaterina at the CNS Summit 2019

LinkedIn Share Twitter Share Facebook Share Email Share

Video courtesy of CNS Summit

LinkedIn Share Twitter Share Facebook Share Email Share

Sign up

Subscribe to receive the latest Compass news.

Subscribe
Back to news and views
  1. Home
  2. George and Ekaterina at the CNS Summit 2019
This website runs on green hosting - verified by thegreenwebfoundation.org

This website is powered by renewable energy

Useful links
  • Contact us
  • About psilocybin therapy
  • About us
  • Join us
  • News and views
Follow us
  • LinkedIn
  • Youtube
  • Twitter
Sign up

Subscribe to receive the latest Compass news.

Subscribe
  • Unsolicited Information Policy
  • Terms
  • Privacy
  • myPathfinder privacy

Compass © 2025. All rights reserved. Made by GIG.

The press releases and articles contained in this section are provided for historical purposes only. The information contained in each press release and article is accurate only as of the date each press release and article was originally issued. Compass disavows any obligation to update the information contained in such press releases and articles after the date of their issuance.

You are now leaving Compass Pathways’ website.

Compass does not control and is not responsible for the content on the website you are about to visit. Compass is providing this link as a convenience, and this link does not imply Compass endorsement of any material on the website you are about to visit. Do you wish to continue?